肝细胞癌合并微血管侵犯术后辅助治疗现状

Progress in adjuvant therapy of hepatocellular carcinoma complicated with microvascular invasion

肝细胞癌是一种具有强侵袭性的恶性肿瘤,尽管外科技术的进步使得单纯手术治疗取得了一定的成效,但仍无法显著改善患者的长期生存状况。研究表明,肝细胞癌术后复发率极高,而微血管侵犯则是导致早期复发和预后不佳的一个重要原因。因此,针对合并微血管侵犯的肝细胞癌患者,术后采取适当的辅助治疗措施对改善其生存预后至关重要。

Hepatocellular carcinoma is a highly aggressive malignant tumor.Although the progress of surgical technology has made some achievements in surgical treatment alone,it still fails to significantly improve the long-term survival of patients.Studies have shown that the recurrence rate of hepatocellular carcinoma is extremely high,while microvascular invasion is an important reason for early recurrence and poor prognosis.Therefore,appropriate postoperative adjuvant therapy measures are crucial to improve the survival prognosis of hepatocellular carcinoma patients with microvascular invasion.